welcome

 

Thursday, 23 June 2011

 

08:30-10:00 | Plenary session: Cutaneous lymphoma: managing cutaneous lymphoma in 2011
Chairs: Robert Knobler (Austria), Antonio Cozzio (Switzerland), Gaëlle Quéreux (France)

  • Molecular pathogenesis of CTCL: basis for a new classification?
    Sean Whittaker (United Kingdom)
  • Targeted therapy in cutaneous lymphoma: what does it means?
    Youn Kim (United States)
  • The optimal use of retinoids in Cutaneous T Cell Lymphomas
    Rudolph Stadler (Germany)
  • Management of Cutaneous B Cell Lymphomas
    Antonio Cozzio (Switzerland)
  • Management of CD30 + T Cell lymphoproliferative disorders?
    Marie Beylot (France)
  • Closing remarks Robert Knobler (Austria)

10:30-10:30 | Coffee break Sponsored by Abbott

10:30-12:10 | Plenary session: Non melanoma skin cancer: managing actinic keratosis
and carcinioma in 2011
Chairs: Colin Morton (United Kingdom), Alessandro Testori (Italy), Christophe Bédane (France)

  • Is there a genetic base for the concept of “field of cancerization”
    Antonio Costanzo (Italy)
  • Management of actinic keratosis
    Eggert Stockfleth (Germany)
  • Management of epithelial cell carcinomas in transplant patients
    Sylvie Euvrard (France)
  • New indications of PDT
    Colin Morton (United Kingdom)
  • Merkeloma and polyomavirus
    Olivier Dereure (France)
  • New hope for advanced non melanoma skin: targeted therapy
    Gregor Jemec (Denmark)
  • Closing remarks Selma Ugurel (Germany)

12h10 | Closing ceremony

 

Top of page